3D cell culture is an unnatural created environment, wherein the biological cells are raised and grown or made to communicate with their nearby surroundings. This is different from the 2 dimensional environments like the Petri dish. Petri dish is a type of cell culture which differs from 3D in a way where 3 dimensional enables the cells to grow in vitro and in all the directions just like the way they would grow in ‘in vivo’. These 3dimensional cultures are raised in bioreactors, the small capsules, wherein the cells can easily grow in spheroids, or cell colonies (3D). Around 300 spheroids are cultured in one single bioreactor.
3D cell culture market is estimated to be over US$ 600.0 Bn in 2017. It is anticipated to grow at a CAGR of 19.8% from 2019 to 2030.
Rising prevalence and incidences of several diseases worldwide has triggered the need for advanced R&D scenario across all sectors of biotechnology, life sciences, pharmaceuticals and research establishments. Both public and private sectors are now focusing on new innovative techniques, ideas to obtain latest breakthroughs in the field of life sciences. According to studies, it was estimated that the total spending on R&D by mid-market biotechnology companies, witnessed an increment of approximately 18% between 2015 and 2016. Growing need to address several forms of ailments has been crucial in dictating the funding and R&D spending by governmental establishments as well as major market players and other research institutes. Increasing R&D investments and spending is anticipated to positively contribute to the growth of the global 3D cell culture market.
Major Key Players of the 3D Cell Culture Market are:
Corning, Thermo Fisher Scientific, Merck & Co., Lonza, 3D Biotek, InSphero, REPROCELL USA Inc., Nano3D Biosciences, Inc., SYNTHECON, INCORPORATED and QGel SA, Lausanne, Switzerland.
No comments:
Post a Comment